BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.602
+0.031 (5.37%)
Nov 20, 2024, 4:00 PM EST - Market open
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$299,467
Market Cap
21.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Spectral AI | 78 |
| bioAffinity Technologies | 75 |
| Pieris Pharmaceuticals | 50 |
| VSee Health | 40 |
| Movano | 30 |
| Spruce Biosciences | 29 |
| iBio, Inc. | 16 |
| NeuroOne Medical Technologies | 16 |
BCTX News
- 3 hours ago - BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study - GlobeNewsWire
- 13 days ago - BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference - GlobeNewsWire
- 17 days ago - BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 - GlobeNewsWire
- 4 weeks ago - BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns - Seeking Alpha
- 4 weeks ago - BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data - GlobeNewsWire
- 5 weeks ago - BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study - GlobeNewsWire
- 7 weeks ago - BriaCell Therapeutics Announces Closing of $5 Million Offering - GlobeNewsWire
- 7 weeks ago - BriaCell Therapeutics Announces $5 Million Offering - GlobeNewsWire